PriceTargets.com logo

OTCMKTS:SONVY - Sonova Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$81.90 As of 10/22/2021 01:00 AM ET
▼ -0.04 (-0.05%)

This chart shows the closing price for SONVY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sonova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SONVY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SONVY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Sonova in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $81.90.

This chart shows the closing price for SONVY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 contributing investment analysts is to buy stock in Sonova. This rating has held steady since October 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
7/25/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/23/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/7/2021UBS GroupReiterated RatingNeutral
9/16/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
6/8/2021Morgan StanleyReiterated RatingEqual Weight
6/3/2021Berenberg BankReiterated RatingHold
5/21/2021UBS GroupReiterated RatingNeutral
5/19/2021Credit Suisse GroupReiterated RatingOutperform
5/19/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
5/19/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
5/19/2021The Goldman Sachs GroupUpgradeSell ➝ Neutral
3/24/2021JPMorgan Chase & Co.Reiterated RatingNeutral
2/18/2021Exane BNP ParibasUpgradeUnderperform ➝ Outperform
2/2/2021UBS GroupReiterated RatingNeutral
12/9/2020Morgan StanleyReiterated RatingEqual Weight
12/1/2020Jefferies Financial GroupUpgradeHold ➝ Buy
11/24/2020JPMorgan Chase & Co.Reiterated RatingNeutral
11/23/2020Berenberg BankReiterated RatingHold
11/17/2020Credit Suisse GroupReiterated RatingOutperform
11/17/2020UBS GroupReiterated RatingNeutral
11/5/2020Berenberg BankReiterated RatingHold
10/8/2020Credit Suisse GroupReiterated RatingOutperform
10/8/2020CitigroupInitiated CoverageNeutral
9/30/2020JPMorgan Chase & Co.Reiterated RatingNeutral
9/29/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
9/29/2020UBS GroupReiterated RatingNeutral
9/2/2020UBS GroupReiterated RatingNeutral
7/27/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight
5/22/2020UBS GroupDowngradeBuy ➝ Neutral
5/21/2020JPMorgan Chase & Co.UpgradeNeutral
5/20/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
5/12/2020Berenberg BankReiterated RatingHold
4/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
4/9/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
1/5/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
10/31/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell
9/10/2019Jefferies Financial GroupUpgradeHold ➝ Buy
1/14/2019UBS GroupUpgradeNeutral ➝ Buy
2/6/2017UBS GroupDowngradeNeutral ➝ Sell
(Data available from 10/23/2016 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/25/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2021

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Sonova logo
Sonova Holding AG engages in the development and production of hearing care solutions. It operates through the Hearing Instruments and Cochlear Implants business segments. The Hearing Instruments segment includes the activities related to the design, development, production, distribution, and servicing of hearing instruments and related products. The Cochlear Implants segment involves the activities relevant to the design, development, production, distribution, and servicing of hearing implants and related products. The firm offers its products under the brands Phonak, Unitron, Hansaton, Connect Hearing, Boots Hearingcare, AudioNova, Geers, and Advanced Bionics. The company was founded in 1947 and is headquartered in Staefa, Switzerland.
Read More

Today's Range

Now: $81.90
Low: $81.27
High: $81.97

50 Day Range

MA: $78.09
Low: $73.27
High: $83.50

52 Week Range

Now: $81.90
Low: $46.75
High: $83.62

Volume

7,774 shs

Average Volume

24,974 shs

Market Capitalization

$25.87 billion

P/E Ratio

49.34

Dividend Yield

0.51%

Beta

0.72

Frequently Asked Questions

What sell-side analysts currently cover shares of Sonova?

The following Wall Street sell-side analysts have issued reports on Sonova in the last twelve months: Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for SONVY.

What is the current price target for Sonova?

0 Wall Street analysts have set twelve-month price targets for Sonova in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sonova in the next year.
View the latest price targets for SONVY.

What is the current consensus analyst rating for Sonova?

Sonova currently has 4 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SONVY will outperform the market and that investors should add to their positions of Sonova.
View the latest ratings for SONVY.

What other companies compete with Sonova?

Other companies that are similar to Sonova include Masimo, Getinge, InMode, CONMED, LivaNova, Outset Medical, BioLife Solutions, ViewRay, Semler Scientific, Natus Medical, TransMedics Group, Cutera, AxoGen, Stereotaxis and Zynex.

How do I contact Sonova's investor relations team?

Sonova's physical mailing address is Laubisrutistrasse 28, Stafa V8, 8712. The company's listed phone number is (158) 928-0101 and its investor relations email address is [email protected] The official website for Sonova is www.sonova.com.